Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients-Reference-Cited by-同舟云学术

Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients

Published:2022-03-11 Issue:10 Volume:101 Page:e29031
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhang Xinyue,Hu Minhao,Li Siyu,Sha Shanyan,Mao Ruoyu,Liu Yu,Li Qiong,Lu Qing,Chen Weili,Zhang Ying,Wang Rong,Xu Huaijin,Wang Jieqiong,Qiao Yu,Chen Ziyi,Wu Huangan,Pan Yuncui,Wang Qian,Zhang Shuhui,Yang Fan,Li Jianwei,Liu Guangyu,Xue Xiaohong,Ji Yajie

Funder

Clinical Research Plan of SHDC

Shanghai Science and Technology Committee

National Natural Science Foundation of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?;Feng;Cancer Commun (Lond),2019

3. Time from completion of neo-adjuvant chemotherapy to surgery: effects on outcomes in breast cancer patients;Arciero;Breast J,2020